|
LHL15 ≥ 0.9
| |
LHL15 < 0.9
| |
---|
Variables
|
Low PNI (n = 7)
|
High PNI (n = 146)
|
p value
|
Low PNI (n = 10)
|
High PNI (n = 26)
|
p value
|
---|
Tumor size (cm)
|
7.0 (2.0–13.0)
|
4.0 (0.5–24.0)
|
n.s
|
3 (1.1–15.0)
|
3.5 (0.7–20.0)
|
n.s
|
Multiple tumor
|
2 (29%)
|
38 (26%)
|
n.s
|
5 (50%)
|
4 (15%)
|
n.s
|
AFP (ng/ml)
|
40 (2–33,430)
|
9 (1–253,875)
|
n.s
|
122 (9–60,105)
|
29 (4–88,940)
|
n.s
|
DCP (mAU/ml)
|
1501 (28–85,330)
|
88 (1–286,400)
|
n.s
|
260 (14–29,182)
|
237 (10–174,400)
|
n.s
|
BCLC stage
| | |
n.s
| | |
n.s
|
0
|
0 (0%)
|
13 (9%)
| |
0 (0%)
|
4 (15%)
| |
A
|
6 (86%)
|
91 (62%)
| |
7 (70%)
|
17 (65%)
| |
B
|
0 (0%)
|
31 (21%)
| |
3 (30%)
|
4 (15%)
| |
C
|
1 (14%)
|
11 (8%)
| |
0 (0%)
|
1 (4%)
| |
Within Milan criteria
|
9 (53%)
|
98 (57%)
|
n.s
|
7 (70%)
|
20 (77%)
|
n.s
|
Tumor differentiation
| | |
n.s
| | | |
Well
|
2 (29%)
|
34 (29%)
| |
0 (0%)
|
6 (29%)
|
n.s
|
Moderately
|
3 (43%)
|
68 (56%)
| |
7 (78%)
|
12 (57%)
| |
Poorly
|
2 (29%)
|
19 (16%)
| |
2 (22%)
|
3 (14%)
| |
Vascular invasion
| | | | | | |
vp ( +)
|
4 (57%)
|
48 (38%)
|
n.s
|
5 (56%)
|
7 (33%)
|
n.s
|
vv ( +)
|
1 (14%)
|
11 (9%)
|
n.s
|
0 (0%)
|
0 (0%)
|
n.s
|
Operation time (minutes)
|
361 (170–526)
|
350 (137–983)
|
n.s
|
277 (159–413)
|
274 (127–580)
|
n.s
|
Blood loss (ml)
|
2865 (520–10,382)
|
1064 (0–36,000)
|
n.s
|
1711 (1270–4192)
|
1500 (56–7341)
|
n.s
|
≥ 2 sectionectomy
|
3 (43%)
|
52 (36%)
|
n.s
|
0 (0%)
|
2 (8%)
|
n.s
|
Complications (C–D ≥ IIIa)
|
1 (14%)
|
29 (20%)
|
n.s
|
4 (40%)
|
4 (15%)
|
n.s
|
Mortality
|
1 (14%)
|
8 (6%)
|
n.s
|
1 (10%)
|
0 (0%)
|
n.s
|
PT-INR on POD5
|
1.19 (1.10–1.71)
|
1.12 (0.92–1.52)
|
n.s
|
1.21 (0.98–1.49)
|
1.18 (0.94–1.51)
|
n.s
|
Total bilirubin on POD5 (mg/dl)
|
1.5 (0.7–11.2)
|
0.9 (0.3–8.3)
|
0.024
|
1.2 (0.5–2.8)
|
1.0 (0.4–4.7)
|
n.s
|
- Differences were considered significant at p < 0.05, shown as italic values
- AFP alpha fetoprotein, DCP des-γ-carboxyprothrombin, BCLC stage Barcelona clinic liver cancer stage, C–D Clavien–Dindo, POD postoperative day, vp ( +) portal vein invasion including microvascular invasion, vv ( +) hepatic vein invasion including microvascular invasion